BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4790261)

  • 1. [Reduced glutathione (GSH) in erythrocytes in myeloproliferative diseases].
    Benöhr HC; Tigges FJ; Waller HD
    Verh Dtsch Ges Inn Med; 1973; 79():461-3. PubMed ID: 4790261
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymes of glutathione synthesis in patients with myeloproliferative disorders.
    Blume KG; Paniker NV; Beutler E
    Clin Chim Acta; 1973 May; 45(3):281-5. PubMed ID: 4513517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary hyperuricemia in hemoblastosis].
    Richter R; Hermanny G; Hofer E; Stobbe H
    Dtsch Gesundheitsw; 1971 Nov; 26(45):2126-30. PubMed ID: 5145658
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1974 Jan; 104(4):133-5. PubMed ID: 4521299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 9. [Free nucleotides of erythrocytes in proliferative diseases of the hemopoietic system].
    Zdebska E; Maj S; Daszyński J; Radziszewski J
    Acta Haematol Pol; 1972; 3(2):119-24. PubMed ID: 4144097
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract]   [Full Text] [Related]  

  • 11. [Content of reduced glutathione in the erythrocytes of idiopathic myelofibrosis and chronic myeloleukemia patients].
    Sorokin EM
    Lab Delo; 1980; (2):112-4. PubMed ID: 6153414
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
    Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of histamine in myeloproliferative disease.
    Gilbert HS; Warner RR; Wasserman LR
    Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders.
    Pegrum GD
    Br J Haematol; 1966 Nov; 12(6):689-96. PubMed ID: 5224278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential diagnostic criteria in chronic myeloproliferative diseases].
    Guseva SA
    Lik Sprava; 1992; (11-12):47-9. PubMed ID: 1292220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukocyte alkaline phosphatase and glucose-6-phosphate-dehydrogenase of the erythrocytes in differential diagnosis of chronic myeloproliferative diseases (author's transl)].
    Hennemann HH; Schief A
    Med Klin; 1974 Aug; 69(34):1359-63. PubMed ID: 4530151
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J; Ebert RF; Gesell MS; Spivak JL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation and fibrinolysis in chronic myeloproliferative syndromes].
    Takahashi K; Shibata A
    Rinsho Ketsueki; 1980 May; 21(5):577-86. PubMed ID: 6997548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.